Controversies in dose-escalation for locally advanced non-small cell lung cancer and the role of proton beam therapy
Author(s) -
Vivek Verma,
Joe Y. Chang
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.03.155
Subject(s) - medicine , proton therapy , lung cancer , proton , oncology , beam (structure) , medical physics , radiation therapy , nuclear physics , optics , physics
We appreciate the insightful commentary by Drs. Choi and Simone regarding the phase II study of concurrent chemotherapy and dose-escalated proton beam therapy (PBT) for locally advanced non-resected non-small cell lung cancer (NSCLC) (1). We wish to add several discussion points that are in concord with the aforementioned piece.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom